Matthew Coffey
Algemeen Directeur bij ONCOLYTICS BIOTECH INC.
Vermogen: 2 M $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Matthew Coffey
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 30 | |
Oncolytics Biotech (U.S.), Inc.
Oncolytics Biotech (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Part of Oncolytics Biotech, Inc., Oncolytics Biotech (U.S.), Inc. manufactures pharmaceutical products. The company is based in Half Moon Bay, CA.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Matthew Coffey via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Chattem, Inc.
Chattem, Inc. Pharmaceuticals: MajorHealth Technology Chattem, Inc. engages in the manufacture of over-the-counter health and beauty care products. It makes anti-dandruff shampoos, medicated skin care, topical pain care, oral care and internal over-the-counter products. The firm distributes its products to mass merchandisers, drugstores and food retail channels. The company was founded by Zeboim Cartter Patten on February 21, 1879 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Executive Officer Director/Board Member | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
E3 LITHIUM LIMITED | Chemicals: Specialty | Director/Board Member | |
SERNOVA CORP. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
PALADIN LABS INC. | Pharmaceuticals: Major | Director/Board Member | |
Export Development Canada
Export Development Canada Finance/Rental/LeasingFinance Export Development Canada engages in the provision of insurance and financial services. It offers bond products, financing, insurance, and risk management solutions to help Canadian exporters and investors expand their international business. The company was founded in 1944 and is headquartered in Ottawa, Canada. | Finance/Rental/Leasing | Director/Board Member Chairman | |
SANOFI | Biotechnology | Corporate Officer/Principal | |
SONOMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Aeras Global TB Vaccine Foundation
Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member | |
Government of Canada | Sovereign | Corporate Officer/Principal | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Chairman | |
River Acquisition Corp.
River Acquisition Corp. MiscellaneousMiscellaneous River Acquisition Corp. is an investment and acquisition company. The private company is based in San Diego, CA and has subsidiaries in the United States. Gregory Irace has been the CEO of the company since 2010. | Miscellaneous | Director/Board Member | |
The University of Chicago | College/University | Doctorate Degree Doctorate Degree | |
US Military Academy | College/University | Undergraduate Degree | |
University of Toronto | College/University | Doctorate Degree Undergraduate Degree | |
The University of Waterloo | College/University | Graduate Degree Undergraduate Degree | |
University of Western Ontario | College/University | Doctorate Degree | |
University of Dayton | College/University | Masters Business Admin | |
University of Calgary | College/University | President Corporate Officer/Principal Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Universidad Nacional Autónoma de México | College/University | Doctorate Degree | |
Order of Canada
Order of Canada Miscellaneous Commercial ServicesCommercial Services Order of Canada is an organization based in Ottawa, Canada. The organization is affiliated with the governor general of Canada, La gouverneure générale du. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Pharmaceuticals: Major | President | |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Chairman Chairman Director/Board Member | |
HYULIM A-TECH CO., LTD. | Textiles | Director/Board Member | |
Pharmaceutical Manufacturers Association of Canada | Chairman | ||
Gairdner Foundation | Director/Board Member | ||
IMV INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Instituto Nacional de Salud Pública de México | Corporate Officer/Principal | ||
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Chairman Chairman | |
Pirus Biological & Vaccine Consulting | President | ||
Instituto Nacional de Ciencias Medicas y Nutricion
Instituto Nacional de Ciencias Medicas y Nutricion Hospital/Nursing ManagementHealth Services Instituto Nacional de Ciencias Medicas y Nutricion operates hospitals. The private company is based in Mexico City, Mexico. | Hospital/Nursing Management | Corporate Officer/Principal | |
1798 Consultants, Inc.
1798 Consultants, Inc. Medical/Nursing ServicesHealth Services 1798 Consultants, Inc. operates as a boutique healthcare advisory firm, which specializes in the areas of access, reimbursement, compliance, and commercialization for the biotechnology, pharmaceutical, medical device, and diagnostic industries. Its services include manage markets consulting, compliance, informatics, reimbursement training, and competitive intelligence. The company was founded by Roshawn Blunt in 2005 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
PROVENTION BIO, INC. | Pharmaceuticals: Major | Chairman | |
ALTIMMUNE, INC. | Biotechnology | Director/Board Member | |
SONA NANOTECH INC. | Chemicals: Specialty | Chairman | |
ADVAXIS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
AYALA PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
Verenigde Staten | 22 |
Canada | 21 |
Mexico | 4 |
Verenigd Koninkrijk | 2 |
Frankrijk | 2 |
Sectoraal
Health Technology | 25 |
Consumer Services | 9 |
Commercial Services | 5 |
Process Industries | 4 |
Finance | 3 |
Operationeel
Director/Board Member | 151 |
Corporate Officer/Principal | 65 |
Independent Dir/Board Member | 59 |
Chairman | 46 |
President | 28 |
Sterkste connecties
Insiders | |
---|---|
James Dinning | 34 |
Bernd Seizinger | 23 |
Leonard Kruimer | 22 |
William A. Cochrane | 21 |
J. Lievonen | 18 |
Linda Hohol | 18 |
Bradley Thompson | 17 |
Jonathan Rigby | 16 |
Wayne Pisano | 14 |
Angela Holtham | 13 |
Deborah Brown | 13 |
Andres Gutiérrez | 13 |
Alan Tuchman | 13 |
Patricia Andrews | 11 |
David Diamond | 11 |
- Beurs
- Insiders
- Matthew Coffey
- Bedrijfsconnecties